𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lessons for culturally competent evaluation from the study of a multicultural initiative

✍ Scribed by Jean A. King; Julie E. Nielsen; Jeanette Colby


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
68 KB
Volume
2004
Category
Article
ISSN
1097-6736

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Bringing together individuals from cultural backgrounds with varied values and norms for expressing conflicting ideals can elevate the tensions inherent in participatory evaluation. As the authors of this chapter found out, even the most deliberate attention to cultural issues does not guarantee a smooth ride.


πŸ“œ SIMILAR VOLUMES


The benefits of a broader perspective in
✍ James C. Coyne; Gregory Brown; Catherine Datto; Martha L. Bruce; Herbert C. Schu πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 1 views

## Abstract The PROSPECT (Prevention of Suicide in Primary Care Elderly — Collaborative Trial) Study evaluates collaborative care for the treatment of current depressive disorders in older primary care patients. Using screening data, we evaluate implications of expanding the focus to additional pat

Evaluating the suitability of planted fo
✍ Peter J. Fashing; Nga Nguyen; Patrick Luteshi; Winstone Opondo; Julie F. Cash; M πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 185 KB πŸ‘ 1 views

## Abstract As natural forest cover declines, planted forests have come to occupy an increasing percentage of the earth's surface, yet we know little about their suitability as alternative habitat for wildlife. Although some primate species use planted forests, few studies have compared primate pop

Evaluation of patients with advanced neu
✍ Iwafuchi, Makoto; Utsumi, Jiro; Tsuchida, Yoshiaki; Kaneko, Michio; Matsuyama, S πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 540 KB

In January 1985, a single protocol consisting of cyclophosphamide, vincristine, tetrahydropyranyl adriamycin, and cis-platinum for the treatment of advanced neuroblastoma was begun nationwide in Japan and was found to improve clinical results significantly in terms of 2-or 3year survival rate. Betw